Journal of cardiothoracic and vascular anesthesia
-
J. Cardiothorac. Vasc. Anesth. · Dec 1999
Clinical TrialIncreased extracellular brain water after coronary artery bypass grafting is avoided by off-pump surgery.
To determine if coronary artery bypass graft (CABG) surgery without cardiopulmonary bypass (CPB) avoids the brain swelling known to occur after CPB, to quantify these brain water compartment changes, and to identify the water shifts as due to intracellular or extracellular water. ⋯ Changes consistent with increased extracellular brain water seen after CABG with CPB were not observed in patients undergoing CABG without CPB. The clinical significance of brain water changes and increased brain water content after surgery with CPB remains undefined.
-
J. Cardiothorac. Vasc. Anesth. · Dec 1999
A multidisciplinary process to improve the efficiency of cardiac operating rooms.
To alter the approach to cardiac operating room services in an attempt to remain competitive in a cost-driven market. ⋯ Development of a working group, with support from the hospital administration, can significantly decrease the time of tasks in a cardiac surgery operating room without adversely affecting morbidity and mortality.
-
J. Cardiothorac. Vasc. Anesth. · Dec 1999
Letter Case ReportsPostoperative delirium and defibrillation.
-
J. Cardiothorac. Vasc. Anesth. · Dec 1999
Randomized Controlled Trial Comparative Study Clinical TrialElderly coronary artery bypass graft patients with left ventricular dysfunction are hemodynamically stable after two different doses of rocuronium.
To clarify the detailed hemodynamic responses to bolus administration of 2x 95% effective dose (ED95) and 3x ED95 of rocuronium in elderly patients with left ventricular dysfunction undergoing elective coronary artery bypass grafting (CABG). ⋯ The results demonstrate that bolus administration of rocuronium (2x to 3x ED95) in combination with high-dose fentanyl provides sufficient cardiovascular stability among elderly CABG patients with left ventricular dysfunction. The cardiovascular profile of the two different bolus doses was similar. Rocuronium, in both doses, appears to be a suitable agent for muscle relaxation, especially for patients who require a high degree of cardiovascular stability.